AbstractA simple process of in vitro folding has been developed for the preparation of hirudin dimer. A variant of recombinant hirudin with Asp33 replaced by Cys was expressed in yeast and isolated by HPLC. Crude Cys33-hirudin contains heterogeneous products that are made of one species of primary sequence. They were together reduced/denatured, and allowed to re-fold in the sodium bicarbonate buffer (pH 8.3) alone. Active, homogeneous Cys33-hirudin monomer folded spontaneously with a first order rate constant of 0.05 ± 0.01 min−1, followed by the oxidation of two Cys33 to produce the pure dimer. The folding yield was 90%. On an equal weight basis, both Cys33-hirudin monomer and the dimer exhibit thrombin inhibitory activity comparable to th...
Almost all therapeutic proteins contain disulfide bonds to stabilize their native structure. Recombi...
[[abstract]]Unsulfated N alpha-acetyl-hirudin45-65 (MDL 27 589), which corresponds to the C-terminus...
: Hirudin from Hirudo medicinalis is a bivalent α-Thrombin (αT) inhibitor, targeting the enzyme acti...
Hirudin is a small (approximately 7 kDa) disulfide-cross-linked polypeptide known as the most potent...
Hirudin is a small (approximately 7 kDa) disulfide-cross-linked polypeptide known as the most potent...
A theoretical model for the folding of proteins containing disulfide bonds is introduced. The model ...
The purification of recombinant hirudin variant 2-Lys47 (rHV2-Lys47), produced by a genetically engi...
The purification of recombinant hirudin variant 2-Lys47 (rHV2-Lys47), produced by a genetically engi...
The purification of recombinant hirudin variant 2-Lys47 (rHV2-Lys47), produced by a genetically engi...
A theoretical model for the folding of proteins containing disulfide bonds is introduced. The mo...
A theoretical model for the folding of proteins containing disulfide bonds is introduced. The mo...
Hirudin is the most potent and specific inhibitor of thrombin, a key enzyme in the coagulation proce...
Hirudin is the most potent and specific inhibitor of the blood-clotting enzyme thrombin so far known...
Almost all therapeutic proteins contain disulfide bonds to stabilize their native structure. Recombi...
Recombinant Saccharomyces cerevisiae was employed to continuously produce hirudin in a membrane cell...
Almost all therapeutic proteins contain disulfide bonds to stabilize their native structure. Recombi...
[[abstract]]Unsulfated N alpha-acetyl-hirudin45-65 (MDL 27 589), which corresponds to the C-terminus...
: Hirudin from Hirudo medicinalis is a bivalent α-Thrombin (αT) inhibitor, targeting the enzyme acti...
Hirudin is a small (approximately 7 kDa) disulfide-cross-linked polypeptide known as the most potent...
Hirudin is a small (approximately 7 kDa) disulfide-cross-linked polypeptide known as the most potent...
A theoretical model for the folding of proteins containing disulfide bonds is introduced. The model ...
The purification of recombinant hirudin variant 2-Lys47 (rHV2-Lys47), produced by a genetically engi...
The purification of recombinant hirudin variant 2-Lys47 (rHV2-Lys47), produced by a genetically engi...
The purification of recombinant hirudin variant 2-Lys47 (rHV2-Lys47), produced by a genetically engi...
A theoretical model for the folding of proteins containing disulfide bonds is introduced. The mo...
A theoretical model for the folding of proteins containing disulfide bonds is introduced. The mo...
Hirudin is the most potent and specific inhibitor of thrombin, a key enzyme in the coagulation proce...
Hirudin is the most potent and specific inhibitor of the blood-clotting enzyme thrombin so far known...
Almost all therapeutic proteins contain disulfide bonds to stabilize their native structure. Recombi...
Recombinant Saccharomyces cerevisiae was employed to continuously produce hirudin in a membrane cell...
Almost all therapeutic proteins contain disulfide bonds to stabilize their native structure. Recombi...
[[abstract]]Unsulfated N alpha-acetyl-hirudin45-65 (MDL 27 589), which corresponds to the C-terminus...
: Hirudin from Hirudo medicinalis is a bivalent α-Thrombin (αT) inhibitor, targeting the enzyme acti...